CMS Finalizes Medicare Rx Regs; Rebate Rules Await Further Guidance
The Centers for Medicare & Medicaid Services will issue a guidance on how Part D plan sponsors should report rebates following the publication of the final implementing regulations
More from Archive
More from Pink Sheet
Julian Beach, interim executive director of healthcare quality and access at the UK drug regulator, the MHRA, tells the Pink Sheet how the agency is responding to increased efforts to develop bacteriophage therapies.
Exclusive analysis by the Pink Sheet explores how non-submissions by pharmaceutical companies to England’s health technology appraisal body are impacting the availability of medicines on the National Health Service.
As South Korea's new president immediately gets to work on setting initial policies, essential drug supplies, R&D incentives and AI-driven digital healthcare are among the key topics in focus.